Intersect ENT, Inc. Sustainability Profile
Intersect ENT, Inc., a leading innovator in the ear, nose, and throat (ENT) industry, is headquartered in the United States. Founded in 2011, the company has made significant strides in developing advanced solutions for chronic sinusitis and other ENT conditions. With a focus on minimally invasive procedures, Intersect ENT's core products, including the Propel® and Sinuva® implants, are designed to improve patient outcomes and enhance recovery. The company has established a strong market position, recognised for its commitment to innovation and patient care. Intersect ENT's unique offerings not only address the needs of healthcare providers but also prioritise patient comfort and satisfaction. As a key player in the ENT space, Intersect ENT continues to shape the future of sinus care with its cutting-edge technologies and dedication to improving quality of life for patients.
DitchCarbon Score
How does Intersect ENT, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Intersect ENT, Inc.'s score of 45 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Intersect ENT, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Medtronic plc, which influences its climate commitments and initiatives. As part of its corporate family relationship with Medtronic plc, Intersect ENT, Inc. inherits climate-related initiatives and targets. Medtronic has established various sustainability goals, including commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to reduce greenhouse gas emissions across their operations, although specific reduction targets for Intersect ENT, Inc. have not been detailed. While no direct emissions data or reduction targets are available for Intersect ENT, Inc., the company's alignment with Medtronic's sustainability efforts suggests a commitment to addressing climate change and reducing carbon footprints in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is Intersect ENT, Inc.'s Industry?
How Carbon Intensive is Intersect ENT, Inc.'s Location?
Intersect ENT, Inc.'s Scope 3 Categories Breakdown
Intersect ENT, Inc.'s Scope 3 emissions, which increased by 48% last year and increased by approximately 48% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 55% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 47% of Scope 3 emissions.
Top Scope 3 Categories
Intersect ENT, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Intersect ENT, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.